Inoda S, Morita R, Hirohashi Y, Torigoe T, Asanuma H, Nakazawa E, et al
The agency noted that the firm had ceased drug production and distribution and initiated a voluntary recall on July 30, 2025, for products with potential microbial contamination
Our state-of-the-art facilities for Phase 1 clinical trials are located in Toronto, Canada and St
Cardiovasc Res 2024: ivabradine, a funny-current (HCN/I_f) blocker, does not abolish the effect, which places the chronotropy on the SR calcium clock rather than the funny channel
More racially and ethnically diverse staff at investigator sites could lead to greater participation by more minority patients in clinical trials a healthcare innovation that can help fix the broken process plagued by a lack of access, diversity, and transparency